| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
| Particulars | Mar 2020 | Mar 2021 |
|---|---|---|
| Revenue | 3.25 | 2.62 |
| Operating profit | 0.26 | 0.04 |
| Net profit | 0.19 | 0.02 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹2.64 | ₹2.74 | ₹2.59 | ₹2.49 |
| Other Income | ₹0.44 | ₹0.24 | ₹0.30 | ₹0.26 |
| Total Revenue | ₹3.07 | ₹2.98 | ₹2.88 | ₹2.75 |
| Total Expenses | ₹2.98 | ₹2.91 | ₹2.83 | ₹2.70 |
| Profit Before Tax | ₹0.09 | ₹0.06 | ₹0.05 | ₹0.05 |
| Tax | ₹0.02 | ₹0.02 | ₹0.01 | ₹0.01 |
| Profit After Tax | ₹0.08 | ₹0.05 | ₹0.04 | ₹0.04 |
| EPS - Basic | ₹0.16 | ₹0.11 | ₹0.10 | ₹0.09 |
| EPS - Diluted | ₹0.12 | ₹0.07 | ₹0.10 | ₹0.09 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹0.09 | ₹0.06 | ₹0.05 | ₹0.05 |
| Income before WC changes | -₹0.13 | ₹0.05 | ₹0.00 | ₹0.04 |
| Change in Assets | -₹0.84 | -₹0.60 | -₹0.23 | -₹0.31 |
| Change in Liabilities | ₹0.41 | -₹0.70 | ₹0.21 | ₹0.08 |
| Change in WC | -₹0.44 | -₹1.30 | -₹0.02 | -₹0.23 |
| Cash flow from Operations | -₹0.58 | -₹1.26 | -₹0.04 | -₹0.21 |
| Cash flow from Investing | ₹1.18 | ₹0.13 | ₹0.49 | ₹0.19 |
| Cash flow from Financing | -₹0.33 | ₹1.14 | -₹0.44 | ₹0.03 |
| Total Cash Flow | ₹0.27 | ₹0.00 | ₹0.01 | ₹0.01 |
| Cash (Start of the year) | ₹0.03 | ₹0.03 | ₹0.02 | ₹0.01 |
| Cash (End of the year) | ₹0.30 | ₹0.03 | ₹0.03 | ₹0.02 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹2.11 | ₹2.90 | ₹2.84 | ₹3.09 |
| Current Assets | ₹6.87 | ₹5.75 | ₹5.15 | ₹4.91 |
| Total Assets | ₹8.97 | ₹8.65 | ₹7.98 | ₹8.00 |
| Current Liabilities | ₹1.60 | ₹1.20 | ₹1.89 | ₹1.69 |
| Net Current Asset | ₹5.26 | ₹4.55 | ₹3.25 | ₹3.22 |
| Non-Current Liabilities | ₹0.24 | ₹0.40 | ₹0.64 | ₹0.90 |
| Equity Capital | ₹7.13 | ₹7.05 | ₹5.45 | ₹5.41 |
| Total Equity & Liabilities | ₹8.97 | ₹8.65 | ₹7.98 | ₹8.00 |
Ganga Pharmaceuticals Limited is an India-based company. The Company is engaged in the production of ayurvedic medicine. Apart from manufacturing, the Company is also into marketing and distribution of ayurvedic medicines. It offers ayurvedic medicines for acidity, antidandruff, antioxidants, blood purifier and skin disorder, constipation, cough and cold, dental care, diarrhea, ear care, female tonic, hair care, hemorrhoids and piles, indigestion, iron tonic, joint pains, kidney stone, liver disorder, rejuvenation tonic, sleep inducers, and offers herbal cosmetics. Its products include Asuka tablets, Dendroil, Ashwo tablets-tonic for body and mind; Raktaj tablets/syrup for skin disorders; Nirmalaya that relieves constipation; Khadira tablets (80 mg.) that relieves cough; Danta Doshahar Manjan for gum and teeth protective; Holetrica capsule that checks diarrhea and corrects digestion; Karnaraj drops ear drops, Femoherb syrup/tablets, and Mahabhrungraj oil.
Ganga Pharmaceuticals Limited share price is ₹12.00 as on 12 Feb, 2026, 14:45 IST.
The Mutual Fund Shareholding in Ganga Pharmaceuticals Limited was 0.00% at the end of Mar 2026.
The 52-week high and low of Ganga Pharmaceuticals Limited share is ₹14.60 and ₹9.35 as of 12 Feb, 2026.
The market capitalisation of Ganga Pharmaceuticals Limited is ₹7.09 Crores as on 12 Feb, 2026.
The stock symbol of Ganga Pharmaceuticals Limited is 539680 on the BSE, and the ISIN is INE615T01017.
To buy Ganga Pharmaceuticals Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Ganga Pharmaceuticals Limited shares closed yesterday at ₹12.00 on BSE
No, shares of Ganga Pharmaceuticals Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Ganga Pharmaceuticals Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.